Source: USANA Health Sciences Form 10-K, Fiscal Year 2025

Summary

USANA Health Sciences' annual report on Form 10-K for fiscal year 2025 — a 53-week year running December 29, 2024 to January 3, 2026 — filed with the SEC on 2026-03-16. Accession number 0000896264-26-000021; filer CIK 0000896264; IRS employer identification number 87-0500306; NYSE.

This is the primary record for how large USANA's Utah direct-selling business is and which direction it is moving. The load-bearing fact in it is a divergence: consolidated net sales rose 8.3% while the core nutritional segment — the direct-selling business — fell 6.9%, with the entire increase coming from Hiya, a children's-vitamin brand USANA acquired in December 2024 that sells direct-to-consumer rather than through a sales force.

Filings and XBRL facts stay retrievable from EDGAR by CIK and accession: https://data.sec.gov/submissions/CIK0000896264.json lists every filing, and https://data.sec.gov/api/xbrl/companyconcept/CIK0000896264/us-gaap/{tag}.json returns tagged facts with the accession that reported each one.

Useful Claims

• Consolidated net sales for FY2025 were $925.3 million, up 8.3% ($70.8 million) from FY2024.
• The increase came from Hiya, which added $130.0 million of incremental sales; the core nutritional segment declined.
• Core nutritional net sales were $793.3 million, down 6.9% year over year.
• Net earnings attributable to USANA fell 74.4% to $10.8 million, against $42.0 million in FY2024 and $63.8 million in FY2023 — attributed to a lower operating margin and a higher effective tax rate.
• USANA had approximately 1,570 employees working in 22 countries as of January 3, 2026, measured by full-time equivalency; 41% of employees are in the United States and 28% in China, and 56% are female.
• USANA counted approximately 387,000 active Customers worldwide in the core nutritional business as of January 3, 2026. "Active Customers" combines Brand Partners (who may sell) with Preferred Customers (who may not), and counts anyone who purchased in the most recent three months — it is not a count of people earning money.
• Principal executive offices are 3838 West Parkway Blvd., Salt Lake City, Utah 84120.
• Manufacturing and quality control sit at the Salt Lake City headquarters, with a separate 54,000-square-foot adjacent facility for food products; USANA states it manufactures approximately 56% of its products in-house.
• Fiscal 2025 was a 53-week year; fiscal 2024 and 2023 were 52-week years, so year-over-year comparisons carry an extra week on the 2025 side.

Verbatim

"Net sales in 2025 increased 8.3%, or $70.8 million, to $925.3 million, compared with 2024. The net sales increase was primarily the result of adding the year-to-date incremental sales for Hiya of $130.0 million, partially offset by a decline in net sales for the core nutritional segment." — Item 7, Management's Discussion and Analysis

"Net earnings attributable to USANA decreased 74.4% to $10.8 million in 2025, when compared with 2024." — Item 7, Management's Discussion and Analysis

"Net sales in our core nutritional business (discussed with our other category) in 2025 were $793.3 million, down 6.9% when compared to the corresponding period of 2024." — Item 7, Management's Discussion and Analysis, Core Nutritional Net Sales

"As of January 3, 2026, we had approximately 1,570 employees working in 22 countries worldwide, as measured by full-time equivalency. The majority of our employee population resides in the United States (41%) and China (28%). Approximately 56% of our worldwide employee population is female." — Item 1, Business (Human Capital)

"We only count as active Customers those Brand Partners and Preferred Customers who have purchased from us at any time during the most recent three-month period." — Item 1, Business

"As of January 3, 2026, we had approximately 387,000 active Customers worldwide in our core nutritional business." — Item 1, Business

"3838 West Parkway Blvd. , Salt Lake City , Utah 84120 (Address of principal executive offices, Zip Code)" — Cover page (spacing as the filing's HTML renders it)

"We conduct manufacturing, production, and quality control operations for approximately 56% of our products in-house. We have established and maintain a manufacturing and quality control facility at our corporate headquarters in Salt Lake City, Utah. We utilize a separate 54,000 square foot manufacturing facility located adjacent to our corporate headquarters to manufacture our food products in-house." — Item 1, Business (Manufacturing and Quality Assurance)

"The core nutritional segment operates on a 52/53-week year, ending on the Saturday closest to December 31. Fiscal year 2025 was a 53-week year and fiscal years 2024 and 2023 were 52-week years." — Notes to Consolidated Financial Statements, Fiscal Year

Multi-year figures as the SEC's own XBRL API returns them (val in USD, accn is the filing that reported it):

2023-01-01..2023-12-30  revenue     921010000   accn 0000896264-24-000093
2023-12-31..2024-12-28  revenue     854503000   accn 0000896264-25-000092
2024-12-29..2026-01-03  revenue     925257000   accn 0000896264-26-000021
2023-01-01..2023-12-30  net income   63788000   accn 0000896264-24-000093
2023-12-31..2024-12-28  net income   42030000   accn 0000896264-25-000092
2024-12-29..2026-01-03  net income   10760000   accn 0000896264-26-000021

Reliability Notes

A Form 10-K is primary tier: filed under securities-law accuracy duties, audited as to its financial statements, and kept permanently by the SEC. For revenue, earnings, headcount, and headquarters it supersedes the company's own website and any press coverage.

Three limits. First, the active Customer count is a company-defined metric, not an audited financial statement figure: it merges sellers with discount buyers and resets on a three-month window, so it cannot be read as "people running a USANA business" or compared across companies whose definitions differ. Second, the 53-week fiscal year inflates FY2025 against FY2024 by roughly a week of trading. Third, this filing describes a fiscal year that ended January 3, 2026 and was already partly superseded when captured: the Q1 FY2026 Form 10-Q (accession 0000896264-26-000034) reports $250.2 million of net sales for the quarter ended April 4, 2026.

Related Pages

• USANA Health Sciences
• Utah's Direct-Selling Industry